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Abstract
Here, we present an approach for identifying brainstem dopaminergic pathways using resting state functional MRI. In a
group of healthy individuals, we searched for significant functional connectivity between dopamine-rich midbrain areas
(substantia nigra; ventral tegmental area) and a striatal region (caudate) that was modulated by both a pharmacological
challenge (the administration of the dopaminergic agonist bromocriptine) and a dopamine-sensitive cognitive trait (an
individual’s working memory capacity). A significant inverted-U shaped connectivity pattern was found in a subset of
midbrain-striatal connections, demonstrating that resting state fMRI data is sufficiently powerful to identify brainstem
neuromodulatory brain networks.
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Introduction
Dopamine is critical for a myriad of different functions ranging
from motor control to high-level cognition [1], and is implicated in
the pathology of neurological and psychiatric disorders such as
Parkinson’s disease and schizophrenia. The midbrain, particularly
the substantia nigra and ventral tegmental area, is the site of the
richest concentration of dopaminergic neurons in the brain, which
project densely to the striatum but also to others regions, most
notably the prefrontal cortex and hippocampus [2]. Here, we
present an approach for identifying brainstem dopaminergic
pathways using resting state functional MRI in humans.
Numerous studies using resting state fMRI data have shown
that neuronal activity is characterized by temporal correlations in
blood oxygen level-dependent (BOLD) signal across disparate
brain regions [3]. These fluctuations seem highly consistent over
time and reflect the presence of intrinsic functional [4] and
structural [5] connectivity. To date, brainstem neuromodulatory
projections, such as those comprising the nigrostriatal dopaminer-
gic system, have not been identified in resting state fMRI data.
Thus, in a group of healthy individuals, we searched for significant
functional connectivity between dopamine-rich midbrain areas
(substantia nigra; ventral tegmental area) and a striatal region
(caudate) that was modulated by both a pharmacological challenge
(the administration of the dopaminergic agonist
bromocriptine) and a dopamine-sensitive cognitive trait (an
individual’s working memory capacity). Given the strong evidence
that the relationship between cognitive performance and dopa-
mine levels follows an inverted-U shaped function [6], and that
working memory capacity can be linked to dopamine synthesis
capacity in the caudate [7], we reasoned that voxels of the




All procedures were approved by The University of California
at Berkeley Committee for the Protection of Human Subjects. All
participants gave their written informed consent.
Participants
Eighteen healthy subjects (ages 18–22, 8 males) underwent two
fMRI sessions after receiving a dopaminergic agonist (1.25 mg
bromocriptine), or placebo, in a randomized, counterbalanced,
double-blind design. Two subjects were excluded after realign-
ment parameters indicated rapid head movement in a direction
larger than the voxel size in that dimension.
Cognitive Task
Baseline working memory capacity was measured by perfor-
mance on the listening version [8] of the Daneman and Carpenter
reading span task [9]. In this task, subjects listened to a series of
sentences for which they were required to remember the last word
of each sentence in the order of presentation. The number of
sentences increased across trials, and the span score was based
upon the number of words correctly recalled. Subjects were
divided into low- and high-span groups based on the span task
score via a median split, with individuals attaining a score of 3.5
and above considered high-span. As a result, 8 subjects were
classified as high-span, and 8 subjects as low-span.
PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e87109
MRI Data Acquisition and Analysis
MRI data for both the bromocriptine and placebo sessions were
acquired on separate days from the behavioral data using a
Siemens 3T Trio Magnetom scanner with a 12-channel head coil.
Five minutes of functional data were collected (gradient echo-
planar pulse sequence; TR=2 s, TE= 32 ms, flip angle = 90; 27
oblique slices, voxel size 1.861.863.45 mm) from subjects while
they rested with their eyes open. Echo planar images (EPI) were
slice-time corrected and realigned via SPM 5 tools. EPI volumes
were then co-registered to each subject’s T1-weighted image, band
pass filtered (0.009,f,0.08) to remove fluctuations outside the
dynamic range of the hemodynamic response function, and
spatially smoothed (gaussian kernel - FWHM 4 mm). A mean time
series was extracted from nuisance ROIs (white matter and
ventricles, CSF segmented from T1 images via FSL tools [10]) and
regressed out of EPI data.
High-resolution T1-weighted images were collected using a MP-
RAGE sequence (TR=2.3 s, TE= 2.98 ms, voxel size: 16161
mm) to enable identification of the substantia nigra and the ventral
tegmental area (VTA). ROIs comprising these dopaminergic
midbrain nuclei were created on each subject’s T1 image via visual
inspection and a fixed set of fill parameters using the 3dfill tool
within mricron (http://www.cabiatl.com/mricro/mricron/stats.
html) to ensure regularity of the ROI across subjects. Figure 1
shows a representative midbrain ROI on a coregistered T1 image
in one participant. The mean time series from midbrain ROIs was
extracted and Pearson’s correlation coefficient was calculated with
all other voxel time series throughout the brain, creating a
connectivity map. R values were transformed to z-scores via the
Fisher transformation (i.e. hyperbolic arctangent) [11]. Co-
registered T1 images were normalized to the Montreal Neurolog-
ical Institute Atlas via SPM 5 tools. Normalization parameters
were used to normalize correlation maps from all subjects to a
common atlas space. Bilateral caudate, putamen and ventral
striatum ROIs were defined using the Talairach Daemon atlas
with WFU Pickatlas software [12–13].
Results
Correlation maps with midbrain seeds were created and the
results were analyzed for group level effects. A t-test was
performed across maps from all subjects, including both placebo
and drug sessions. Significant functional connectivity with the
midbrain, irrespective of drug condition, was observed in the
bilateral thalamus, dorsal and ventral striatum, globus pallidus,
medial frontal cortex, medial temporal lobes and cerebellum (see
Figure 2).
We sought to further investigate whether the observed midbrain
connectivity with other brain regions actually reflected dopami-
nergic projections by assessing whether connectivity was modu-
lated by both the administration of the dopaminergic agonist
bromocriptine and an individual’s working memory capacity (a
dopamine sensitive cognitive trait). Prior human studies have
demonstrated that the effects of dopaminergic drugs on cognition
depend on an individual’s baseline working memory capacity, as
measured by span tasks [14]. Specifically, dopaminergic agonists
improve cognition in low-span subjects, but impair cognition in
high-span subjects, consistent with an inverted-U shaped model of
dopamine function [6]. This finding likely reflects different
baseline dopamine levels among individuals (low span - low
dopamine; high span - high dopamine). With PET scanning, we
previously confirmed this hypothesis by finding a significant
positive correlation between dopamine synthesis capacity in the
left caudate nucleus and working memory span [7]. Thus, if
midbrain-caudate connectivity reflects dopaminergic pathways,
the magnitude of this relationship in resting data should exhibit an
inverted-U shaped function, based on an individual’s working
memory capacity (as measured by the listening span test [8]) and
the drug administered.
Midbrain correlation values were extracted from the bilateral
caudate voxels in all subjects and sessions and entered into a 262
ANOVA with factors of drug (bromocriptine vs placebo) and span
(high vs low). A quadratic contrast (20.5 0.5 0.5 20.5) was then
created to determine whether these voxels were consistent with a
hypothesized inverted-U shaped function. A significant interaction
between drug and span was found in voxels within the left caudate
nucleus (p , .05, FDR, small volume correction). These caudate
voxels exhibited increased connectivity with the midbrain in low
span subjects on bromocriptine relative to placebo, whereas the
opposite effect was found in high span subjects (see Figure 3). On
the top of Figure 3, midbrain-caudate connectivity values from
these voxels are plotted separated by span group and drug
condition, illustrating the inverted-U shaped response. On the
bottom of Figure 3, midbrain-caudate connectivity values are
plotted against span scores across subjects in both the placebo and
drug conditions. Consistent with an inverted-U shaped function, a
significant positive correlation between midbrain-caudate connec-
tivity and span was found in the placebo condition (r = 0.66,
p = 0.003). That is, individuals with higher span had higher
midbrain-caudate connectivity. In the drug session, there was a
Figure 1. Representative bilateral midbrain ROI (red) on a co-registered T1 image in one participant.
doi:10.1371/journal.pone.0087109.g001
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significant negative correlation between midbrain-caudate connec-
tivity and span (r =20.69, p= 0.005). Notably, this correlation
was significantly greater in the placebo than the drug condition
(Z= 4.14, p , 0.0001). Removing the outlier low span subject did
not affect the significant group difference shown in Figure 3.
We also sought to determine whether caudate voxels that
exhibited an inverted-U shaped connectivity pattern with the
midbrain across subjects were the same caudate voxels that
exhibited significant correlations with the midbrain across all
subjects and drug conditions. In other words, could these caudate
voxels be identified solely on the strength of their connectivity with
presumptive dopaminergic regions in the midbrain, independent
of span and response to bromocriptine? Our motivation for this
analysis was to determine whether there is added value in using a
proxy for measuring brain dopamine (e.g. the combination of span
and dopaminergic agonist administration) for identifying dopami-
nergic pathways in resting fMRI data. These results, presented on
the left side of Figure 4 as a Venn diagram, illustrate that there is
only a small degree of overlap between caudate voxels (either left-
or right-sided) exhibiting inverted-U shaped connectivity and
those identified by correlation across all subjects and drug sessions.
Specifically, even when voxels demonstrating the U-shaped
response are loosely thresholded (p , 0.05, uncorrected), it can
be seen that only 13% of the voxels (122/955 voxels) that exhibit
significant midbrain-caudate connectivity across all subjects and
drug sessions (left circle) also show an inverted-U shaped response
dependent on span and drug (intersection of circles). This
percentage is further reduced when a higher, but still relaxed,
statistical threshold is applied (26/743 or 4% overlap at p , 0.01,
uncorrected).
It is also conceivable that span alone may reliably identify these
voxels. However, if one only considers the caudate voxels that
exhibit increased connectivity with midbrain for high span subjects
compared to low span (a smaller set of voxels, indicated in the
leftmost circle in the right-hand Venn diagram), it can be seen on
the right side of Figure 4 that only 50% of these voxels (61/122
voxels) also show an inverted-U shaped response dependent on
both span and drug (intersection of circles, right-hand cell) – again,
even when these voxels are loosely thresholded (p , 0.05
uncorrected). This percentage is reduced when a slightly higher
Figure 2. Whole-brain correlation maps with midbrain seeds across all subjects and across both placebo and bromocriptine
sessions. Maps are thresholded at p , .05 FDR corrected with a minimum cluster size of 20 voxels. The color bar indicates t values.
doi:10.1371/journal.pone.0087109.g002
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statistical threshold is applied (4/28 voxels or 14% overlap at p ,
0.01, uncorrected). Thus, these findings indicate that most
‘‘dopaminergic pathway’’ voxels would remain unidentified
without considering the effect of a dopaminergic drug and
dopamine-dependent behavioral measures (i.e. an individual’s
working memory capacity).
We further sought to investigate whether these potentially
dopaminergic voxels were distributed homogeneously throughout
the caudate. Loosely-thresholded voxels demonstrating midbrain
connectivity profiles consistent with an inverted U-shaped function
(p , 0.05, uncorrected) were observed throughout the head, body
and tail of the caudate nucleus (see Figure 5, top). Evidence from
anatomical investigations suggests the existence of multiple distinct
circuits in the caudate, each receiving input from its own cortical
region [15]. In a recent meta analysis using imaging data from the
BrainMap database [16–18] Robinson et al [19] were able to
segregate activity in the head and body of the caudate, thought to
be primarily ‘‘cognitive’’, from activity in the tail, thought to be
primarily ‘‘motor’’. Thus, we divided our caudate mask into head/
body and tail regions by estimating the position of the
interventricular foramina of Monro [19]. The head/body was
defined to be all caudate voxels anterior to a coronal slice at MNI
Figure 3. Correlations between midbrain and left caudate activity: voxels demonstrating a significant inverted-U shaped
effect. Top. Mean Z scores of correlations of midbrain-caudate connectivity divided into span groups and drug conditions. Error bars indicate
standard error. Bottom. Mean Z scores of correlations of midbrain-caudate connectivity with performance on the listening span test during placebo
or drug condition. Working memory span was measured as the number of words recalled on the listening span task (see Methods).
doi:10.1371/journal.pone.0087109.g003
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y= 2 whereas all other caudate voxels were defined to be the tail
(see Figure 5, middle). This division yielded 1562 and 394 voxels
in the head/body and tail respectively. We then performed the
same overlap analysis as performed on the entire caudate in each
region separately (see Figure 5, bottom). The proportion of
overlap in the caudate tail was significantly higher than that in the
head/body (X2 (1, N=394,1562) = 58.28, p=2.27610214). This
difference was even larger in voxels displaying a span effect (X2 (1,
N=394,1562) = 75.13, p=4.4610218).
Even though only the caudate exhibited a u-shaped response in
our map-wise analysis, we also performed an exploratory search
for such effects in other midbrain dopaminergic targets in the basal
ganglia. Thus, voxels from the putamen and ventral striatum were
subjected to the same overlap analysis described above, quanti-
fying the degree to which they showed connectivity with the
midbrain and exhibited changes in connectivity consistent with the
inverted-U shaped function. Unlike the caudate, neither of these
regions contained voxels that exhibited an inverted-U shaped
response dependent on span and drug at an appropriate small
volume correction. Even at a relaxed statistical threshold of p ,
.05 (uncorrected), only 69 of 2073 voxels in the putamen showed
an inverted-U response. In the ventral striatum, no voxels showed
an inverted-U response, although the small size of this region (47
voxels) may make a null result more likely.
Discussion
These fMRI data demonstrate that significant correlations of
spontaneous BOLD activity exist between the midbrain and the
caudate during the resting state. The likelihood that these
functionally connected regions reflect dopaminergic pathways is
supported by our finding that dopaminergic augmentation with
bromocriptine modulated midbrain-caudate connectivity. More-
over, this drug effect exhibited an inverted U-shaped response
when an individual’s working memory capacity was also consid-
ered. That is, individuals with low baseline working memory
capacity (with presumably lower dopamine levels) exhibited
increased midbrain-caudate connectivity following administration
of bromocriptine, whereas those individuals with high baseline
working memory capacity exhibited decreased midbrain-caudate
connectivity.
Only a limited number of studies to date have investigated
patterns of connectivity within putative dopaminergic circuitry
after the administration of selective dopaminergic agonists, and
most have done so with data acquired during the performance of a
behavioral task. Moreover, all of these studies have only reported
changes in frontal-striatal connectivity with dopaminergic modu-
lation [20–22] rather than in midbrain-striatal connectivity. One
relevant study examined the effect of dopaminergic modulation of
frontal-striatal circuitry during the performance of a working
memory task [23]. It was observed that frontal-striatal connectivity
varied in an inverted-U shaped manner and correlated with
performance. Other dopaminergic studies with other cognitive
tasks have obtained similar findings. A study by Honey and
colleagues found that the selective D2 antagonist sulpiride
increased midbrain-caudate connectivity, while the dopamine
reuptake inhibitor methylphenidate decreased it [24]. Using
structural equation modeling to assess effective connectivity
between midbrain, caudate, thalamus, and prefrontal cortex,
these authors also noted significant drug-induced changes in the
directional path from midbrain to caudate: as above, sulpiride
increased the effective connectivity and methylphenidate de-
creased it. In summary, all of these studies demonstrate that an
inverted-U shaped pattern of connectivity can be demonstrated in
midbrain-striatal-frontal circuitry.
In contrast with our findings in the caudate, neither putamen
nor ventral striatum contained voxels that exhibited an inverted-U
shaped response dependent on span and drug when appropriately
thresholded, a result that did not change markedly even when
these voxels were evaluated at reduced statistical significance. This
finding may reflect the fact that dopamine synthesis in the caudate,
but not other striatal regions, has been shown to correlate with
working memory capacity [7], and is consistent with the particular
sensitivity of the caudate to dopaminergic modulation [24]. On the
other hand, the lack of significant findings in these regions may
indicate the need for more sensitive measurement techniques or
the use of other cognitive tasks.
An important point that emerges from our study is that not all
significant correlations between midbrain and caudate voxels in
resting fMRI data likely represent dopaminergic pathways. In
addition, the correlations we observed may not necessarily result
solely from correlated activity induced by monosynaptic connec-
tions between midbrain and striatum. In keeping with these ideas,
our overlap analysis revealed that only a small proportion of voxels
exhibiting correlated activity between the midbrain and striatum
in resting state BOLD data demonstrated effects consistent with
dopaminergic modulation. Further, even within a given structure
like the caudate, our analysis reveals regional variation in the
proportion of correlated voxels that were likely to be dopaminer-
gic. What may be the source of significant correlations between
other midbrain and caudate voxels? One source may be neural in
origin. For example, not all VTA projections from the midbrain to
the striatum are dopaminergic [25]. Another source may be non-
neural in origin. For example, physiological processes such as
cardiac pulsatility and respiration [26] can lead to increased
correlations between any two brain regions, especially brainstem
structures. Notably, these latter processes should not affect the
results of our analysis as the drug and span factors interact to
produce effects in opposing directions. Future studies should be
Figure 4. Venn diagrams illustrating degree of overlap. Left.
Venn diagram illustrates the degree of overlap between caudate voxels
identified as correlated with the midbrain (p , 0.05, FDR and small-
volume corrected) collapsed across span and drug condition (left circle)
and caudate voxels identified as having an inverted-U shaped
relationship with the midbrain (p , 0.05, uncorrected; right
circle). Only 122/(122+833) voxels (13%) exhibiting significant mid-
brain-caudate connectivity also exhibit an inverted –U shaped response
dependent on span and drug. Right. Venn diagram illustrates the
degree of overlap between caudate voxels identified as having greater
connectivity with the midbrain in higher span subjects in the placebo
sessions (left circle) and caudate voxels identified as having an inverted-
U shaped relationship with the midbrain (p , 0.05, uncorrected). Only
61/(61+61) voxels (50%) exhibiting a significant increase in midbrain-
caudate connectivity based on span also exhibit an inverted-U shaped
response dependent on span and drug. The number of voxels is
presented within the circles.
doi:10.1371/journal.pone.0087109.g004
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aimed at identifying these other sources of brainstem-basal ganglia
connectivity in BOLD data. In summary, we argue that sensitivity
to dopamine manipulations, as we have presented here, represents
an important approach for defining and confirming putative
dopamine connections arising from the midbrain.
These data also provide constraints on potential neural
mechanisms. Bromocriptine increased mesostriatal connectivity
in subjects with low baseline dopamine tone, but tended to
decrease it in subjects with high baseline dopamine tone. Because
D2 receptors can be found both pre- and post-synaptically [27],
these findings suggest that the targets of bromocriptine may be
influenced by dopamine tone – e.g. that in the context of higher
dopamine tone, presynaptic D2 autoreceptors may be more
rapidly engaged, thereby reducing dopamine signaling and
mesostriatal functional connectivity, than in the case in which
dopamine tone is low. While speculative, such models emphasize
that work in other animals would benefit from a focus on
individual differences in dopamine tone, as well as their impact on
circuit function, when considering the mechanisms underlying the
effects of dopamine manipulations.
In conclusion, our results suggest that brainstem neuromodu-
latory systems can be identified in resting state fMRI data,
potentially providing an exciting new avenue for investigating the
link between brainstem neuromodulatory function and behavior.
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Figure 5. Division of the caudate into a head/body and tail regions is displayed at the top of the figure. Venn diagrams illustrate the
degree of overlap between caudate voxels (middle figure – head/body; bottom figure – tail) identified as correlated with the midbrain (p , .05, FDR
and small-volume corrected) collapsed across span and drug condition (left circle) and caudate voxels identified as having an inverted-U shaped
relationship with the midbrain (p , 0.05, uncorrected; right circle). A significantly greater percentage of overlapping voxels are present in the tail
than the head/body of the caudate.
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